Skip to main content

Dodge & Cox

Position in GSK — GSK plc

CIK 200217 San Francisco, CA

Position in GSK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,526,513,683
-$711,095,852 QoQ
Shares Held
48,197,514
-17.8% QoQ
Ownership
2.41%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
#2
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in GSK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Dodge & Cox holds $7,907,700,561 across 13 Drug Manufacturers - General names. GSK ranks #2 (32.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 GSK
GSK plc
This page
48,197,514 $2,526,513,683

All Filings in GSK

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,082,240,344 173,259,068
2026-06-30 $2,526,513,683 48,197,514
2026-03-31 $3,237,609,535 58,662,974
2025-12-31 $3,360,121,199 68,517,969
2025-09-30 $3,383,905,159 78,403,734
2025-06-30 $3,024,302,169 78,757,869
2025-03-31 $3,046,972,010 78,651,833
2024-12-31 $2,314,671,643 68,440,912
2024-09-30 $2,783,403,223 68,087,163
2024-06-30 $2,630,979,813 68,337,138
2024-03-31 $2,952,127,143 68,862,308
2023-12-31 $2,558,132,948 69,026,793
2023-09-30 $2,511,442,883 69,281,183
2023-06-30 $2,480,945,591 69,611,268
2023-03-31 $2,480,177,479 69,707,068
2022-12-31 $2,281,743,933 64,932,952
2022-09-30 $1,724,126,796 58,583,989
2022-06-30 $3,169,735,403 74,242,722
2022-03-31 $3,663,579,347 85,750,621
2021-12-31 $3,828,756,296 88,519,444
2021-09-30 $3,298,591,735 88,017,914
2021-06-30 $3,445,050,099 88,209,189
2021-03-31 $3,078,571,500 87,947,245
2020-12-31 $2,271,568,005 62,935,758
2020-09-30 $1,661,303,257 45,000,656
2020-06-30 $1,661,193,483 41,522,745
2020-03-31 $1,636,476,858 44,035,690